Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus

International Journal of Cardiology

Volumn 122, Issue 3, 2007, Pages

  Ihm, Sang Hyun ^a   Youn, Ho Joong ^a   Shin, Dong Il ^a   Jang, Sung Won ^a   Park, Chul Soo ^a   Kim, Pum Joon ^a   Kim, Hee Yeol ^a   Chang, Kiyuk ^a   Seung, Ki Bae ^a   Kim, Jae Hyung ^a   Choi, Kyu Bo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Diabetes; Diastolic function; Echocardiography; Myocardial fibrosis; Procollagen

Indexed keywords

PROCOLLAGEN; PROCOLLAGEN TYPE 1 PROPEPTIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE FIBROSIS; HEART VENTRICLE FILLING; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; HUMANS; PEPTIDE FRAGMENTS; PROCOLLAGEN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 35348997928     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.057     Document Type: Article

References (12)

1. Mildenberger R.R., Bar-Shlomo B., Druck M.N., et al. Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol 4 (1984) 234-278
2. Paillole C., Dahan M., Paycha F., et al. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol 64 (1989) 1010-1016
3. Bell D.S. Diabetic cardiomyopathy A unique entity or a complication of coronary artery disease?. Diabetes Care 18 (1995) 708-714
4. Mizushige K., Yao L., Noma T., et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101 (2000) 899-907
5. Lopez B., Querejeta R., Varo N., et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 104 (2001) 286-291
6. Laviades C., Varo N., Diez J., et al. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 36 (2000) 517-522
7. Lopez B., Gonzalez A., Varo N., et al. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38 (2001) 1222-1226
8. Querejeta R., Varo N., Lopez B., et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101 (2000) 1729-1735
9. Lombardi R., Betocchi S., Losi M.A., et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108 (2003) 1455-1460
10. Youn H.J., Ihm S.H., Lee J.M., et al. Relation between flow reserve capacity of penetrating intramyocardial coronary arteries and myocardial fibrosis in hypertension: study using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 19 (2006) 373-378
11. Roongsritong C., Bradley J., Sutthiwan P., Simoni J., Arif A., and Meyerrose G. Elevated carboxy-terminal peptide of procollagen type I in elderly patients with diastolic dysfunction. Am J Med Sci 331 (2006) 131-133
12. Gonzalez-Vilchez F., Ayuela J., Ares M., Pi J., Castillo L., and Martin-Duran R. Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients. Int J Cardiol 101 (2005) 53-58